Complete Response in 5 Out of 38 Patients with Advanced Hepatocellular Carcinoma Treated with Stem Cell Differentiation Stage Factors: Case Reports from a Single Centre

Publisher： Bentham Science Publishers

E-ISSN： 1873-4316|12|2|254-260

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.12, Iss.2, 2011-02, pp. : 254-260

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Stem Cell Differentiation Stage Factors from Zebrafish Embryo: A Novel Strategy to Modulate the Fate of Normal and Pathological Human (Stem) Cells

By  

Current Pharmaceutical Biotechnology, Vol. 16, Iss. 9, 2015-01 ,pp. : 782-792

Bentham Science Publishers

Access to resources Recommend Favorite

Zebrafish Stem Cell Differentiation Stage Factors Suppress Bcl-xL Release and Enhance 5-Fu-Mediated Apoptosis in Colon Cancer Cells

By  

Current Pharmaceutical Biotechnology, Vol. 12, Iss. 2, 2011-02 ,pp. : 261-267

Bentham Science Publishers

Access to resources Recommend Favorite

Cancer Cell Reprogramming: Stem Cell Differentiation Stage Factors and An Agent Based Model to Optimize Cancer Treatment

By  

Current Pharmaceutical Biotechnology, Vol. 12, Iss. 2, 2011-02 ,pp. : 231-242

Bentham Science Publishers

Access to resources Recommend Favorite

Sustained complete remission of advanced hepatocellular carcinoma with sorafenib therapy

By  

Journal of Digestive Diseases, Vol. 16, Iss. 9, 2015-09 ,pp. : 537-540

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treating advanced hepatocellular carcinoma: How to get out of first gear

By Harding James J.   Abou-Alfa Ghassan K.  

Cancer, Vol. 120, Iss. 20, 2014-10 ,pp. : 3122-3130

Blackwell Publishing

Access to resources Recommend Favorite